Skip to content
2000
Volume 11, Issue 1
  • ISSN: 2211-5560
  • E-ISSN:

Abstract

A deficit in brain serotonin (5-hydroxytryptamine; 5-HT) is implicated in a number of psychiatric illnesses, including depression. The treatment efficacy of this highly prevalent brain disorder is not adequate largely due to the depletion of serotonin stores. Tryptophan, an essential amino acid, is the sole precursor of serotonin; its systemic or oral administration increases serotonin synthesis because tryptophan hydroxylase, the rate-limiting enzyme of 5-HT biosynthesis, is physiologically unsaturated with its substrate. The present article targets the importance of tryptophan supplementation in treating serotonin deficiency and improving therapeutic intervention for depression and other serotonin deficiency brain disorders.

Loading

Article metrics loading...

/content/journals/cpsp/10.2174/2211556010666211202104548
2022-04-01
2024-11-23
Loading full text...

Full text loading...

/content/journals/cpsp/10.2174/2211556010666211202104548
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test